- News Home
12 December 2013 1:00 pm ,
Vol. 342 ,
Evolutionary biologists have long studied how the Mexican tetra, a drab fish that lives in rivers and creeks but has...
Victorian astronomers spent countless hours laboriously charting the positions of stars in the sky. Such sky mapping,...
In an ambitious project to study 1000 years of sickness and health, researchers are excavating the graveyard of the now...
Stefan Behnisch has won awards for designing science labs and other buildings that are smart, sustainable, and...
The iconic 125-year-old Lick Observatory on Mount Hamilton near San Jose, California, is facing the threat of closure...
Recent results from the Curiosity Mars rover have helped scientists formulate a plan for the next phase of its mission...
A new, remarkably powerful drug that cripples the hepatitis C virus (HCV) came to market last week, but it sells for $...
In pretoothbrush populations, gumlines would often be marred by a thick, visible crust of calcium phosphate, food...
- 12 December 2013 1:00 pm , Vol. 342 , #6164
- About Us
Live Chat: Too Dangerous to Publish?
25 April 2012 8:38 am
See below for the chat box. Join us each Thursday at 3 p.m. EDT for a live conversation with leading scientists and expert reporters.
On Thursday, a U.S. Senate committee will hold a hearing that will explore how the government should regulate dual use research of concern (DURC) that could be used for good and evil. The hearings come in the wake of controversy over two studies that show how to make the H5N1 avian influenza virus transmissible between mammals, potentially setting off a pandemic. In response to that episode, the U.S. government recently adopted new rules for reviewing some proposed studies for DURC, and other nations are considering similar rules.
But is some biological research simply too dangerous to publish—or conduct in the first place? Will DURC rules unnecessarily bottle up potentially beneficial research? Or do they fall short of keeping us safe? How do we find the right balance between the free flow of science and the need for security?
Join us for a live chat at 3 p.m. EDT on Thursday, 26 April, on this page. You can leave your questions in the comment box below before the chat starts. The full text of the chat will be archived on this page.
Save to my calendar
Gregory Viglianti is the director of Graduate Studies in the Department of Microbiology at the Boston University (BU) School of Medicine. He helped set up one of the first screening programs for dual use research at a U.S. university, and helps train BU faculty members on dual use issues.